Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Observational

Optimization Strategy of Carotid Artery Stenosis

NCT05629000 · tracked via the Priya Life Science China tracker
Phase
Observational
Started
2015-01-01
Last updated
2022-11-29

Condition(s) studied

Carotid Artery Stenosis

Investigational drug(s) / intervention(s)

Carotid revascularizationMRI-PWICTAPET/MRIUltrasound

Carotid revascularization: All patients received carotid revascularization surgery at Peking Union Medical College Hospital.

MRI-PWI: Multi-modal MRI before and after surgery.

CTA: CTA before and after surgery.

PET/MRI: PET/MRI before surgery.

Ultrasound: Ultrasound before and after surgery.

Study summary

The goal of this observational study is to learn about how to utilize multiple evaluation techniques in carotid artery stenosis patients for optimizing assessment of diagnosis and treatment strategy.

The main questions it aims to answer are:

* Identify best strategy that use multi-modal MRI and CT to assess patients' cerebral lesions and perfusion.
* Identify best strategy that use multi-modal MRI, PET-MRI ultrasound and CT to assess components and characters of patients' carotid plaques.

Participants will accept imaging examination before and after surgery. And doctors will collect basic characteristics, imaging results and biological samples of patients for analysis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. patients with severe stenosis (≥50%) or near-occlusion diagnosed by computed tomographic angiogram; 2. patients received carotid endarterectomy at Peking Union Medical College Hospital Exclusion Criteria: (1) Any contraindication to image examination; (3) refuse to sign the Informed consent.

Primary outcome measure(s)

  • stroke — During hospital stay, usually 7-30 days post operation
    perioperative stroke
  • cardiac infarction — During hospital stay, usually 7-30 days post operation
    perioperative cardiac infarction
  • transient ischemic attack — During hospital stay, usually 7-30 days post operation
    perioperative transient ischemic attack
  • cerebral hyperperfusion syndrome — During hospital stay, usually 7-30 days post operation
    perioperative cerebral hyperperfusion syndrome
  • death — During hospital stay, usually 7-30 days post operation
    perioperative death

Trial sites (1)

FacilityCityRegionStatus
vascular surgery department of PUMCH Beijing Beijing Municipality Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05629000 on ClinicalTrials.gov ↗ ← All trials in China